These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11214765)

  • 21. Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough.
    Tenenbaum A; Grossman E; Shemesh J; Fisman EZ; Nosrati I; Motro M
    Am J Hypertens; 2000 Jul; 13(7):776-82. PubMed ID: 10933569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of ACE inhibitors and aspirin in patients with congestive heart failure.
    Song KH; Fedyk R; Hoover R
    Ann Pharmacother; 1999 Mar; 33(3):375-7. PubMed ID: 10200865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous bradykinin suppresses myocardial fibrosis through the cardiac-generated endothelin system under chronic angiotensin-converting enzyme inhibition in heart failure.
    Fujii M; Wada A; Ohnishi M; Tsutamoto T; Matsumoto T; Yamamoto T; Takayama T; Dohke T; Isono T; Eguchi Y; Horie M
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S346-9. PubMed ID: 15838317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure.
    Hall D; Zeitler H; Rudolph W
    J Am Coll Cardiol; 1992 Dec; 20(7):1549-55. PubMed ID: 1452929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair.
    Salata K; Syed M; Hussain MA; Eikelboom R; de Mestral C; Verma S; Al-Omran M
    J Vasc Surg; 2018 Feb; 67(2):629-636.e2. PubMed ID: 29175038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy.
    Neutel JM
    Curr Med Res Opin; 2010 Jan; 26(1):213-22. PubMed ID: 19921961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining aspirin with angiotensin converting enzyme inhibitors in heart failure: how safe is it?
    Mehta H; Mahajan A; Bansal N; Vaidya S; Pathak L
    J Assoc Physicians India; 1998 Nov; 46(11):953-6. PubMed ID: 11229224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
    Bakris GL; Weir MR
    Arch Intern Med; 2000 Mar; 160(5):685-93. PubMed ID: 10724055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes.
    Gillespie EL; White CM; Kardas M; Lindberg M; Coleman CI
    Diabetes Care; 2005 Sep; 28(9):2261-6. PubMed ID: 16123505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin II receptor blockers: current status and future prospects].
    Corvol P; Plouin PF
    Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
    Ong HT
    J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined aspirin/ACE inhibitor treatment for CHF.
    Olson KL
    Ann Pharmacother; 2001 Dec; 35(12):1653-8. PubMed ID: 11793637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
    Leor J; Reicher-Reiss H; Goldbourt U; Boyko V; Gottlieb S; Battler A; Behar S
    J Am Coll Cardiol; 1999 Jun; 33(7):1920-5. PubMed ID: 10362194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health outcomes and economic consequences of using angiotensin-converting enzyme inhibitors in comparison with angiotensin receptor blockers in the treatment of arterial hypertension in the contemporary Polish setting.
    Wrona W; Budka K; Filipiak KJ; Niewada M; Wojtyniak B; Zdrojewski T
    Kardiol Pol; 2016; 74(9):1016-24. PubMed ID: 27112942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications.
    Sarkar P; Nicholson G; Hall G
    Can J Anaesth; 2006 Oct; 53(10):994-1003. PubMed ID: 16987854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
    Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF
    J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events.
    Enseleit F; Hürlimann D; Lüscher TF
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S21-30. PubMed ID: 11392475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effect of angiotensin converting enzyme inhibitors and angiotensin receptors blockers on aspirin antiplatelet effect.
    Al-Azzam SI; Alzoubi KH; Khabour OF; Quttina M; Zayadeen R
    Int J Clin Pharmacol Ther; 2016 Feb; 54(2):96-101. PubMed ID: 26709600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials.
    Bangalore S; Fakheri R; Toklu B; Ogedegbe G; Weintraub H; Messerli FH
    Mayo Clin Proc; 2016 Jan; 91(1):51-60. PubMed ID: 26763511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.